PR Newswire
NEW YORK, Feb. 21, 2019
NEW YORK, Feb. 21, 2019 /PRNewswire/ -- Rowley Law PLLC is
investigating potential claims against Immune Design Corp. (NASDAQ: IMDZ) and its board of directors for breach of fiduciary duty
concerning the proposed acquisition of the company by Merck Sharp & Dohme Corp. (NYSE: MRK). Stockholders will receive
$5.85 for each share of Immune Design Corp. stock that they hold. The transaction is valued at
approximately $300 million and is expected to close in the second quarter of 2019.
If you are a stockholder of Immune Design Corp. and are interested in obtaining additional information regarding this
investigation, please visit us at: http://www.rowleylawpllc.com/investigation/imdz. You may also contact Shane Rowley,
Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com,
or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-immune-design-corp-300799928.html
SOURCE Rowley Law PLLC